GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » InnovAge Holding Corp (NAS:INNV) » Definitions » Gross Margin %

INNV (InnovAge Holding) Gross Margin % : 16.84% (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is InnovAge Holding Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. InnovAge Holding's Gross Profit for the three months ended in Sep. 2024 was $34.5 Mil. InnovAge Holding's Revenue for the three months ended in Sep. 2024 was $205.1 Mil. Therefore, InnovAge Holding's Gross Margin % for the quarter that ended in Sep. 2024 was 16.84%.

Warning Sign:

InnovAge Holding Corp gross margin has been in long-term decline. The average rate of decline per year is -9.5%.


The historical rank and industry rank for InnovAge Holding's Gross Margin % or its related term are showing as below:

INNV' s Gross Margin % Range Over the Past 10 Years
Min: 14.72   Med: 21.57   Max: 27.29
Current: 17.64


During the past 6 years, the highest Gross Margin % of InnovAge Holding was 27.29%. The lowest was 14.72%. And the median was 21.57%.

INNV's Gross Margin % is ranked worse than
86.29% of 620 companies
in the Healthcare Providers & Services industry
Industry Median: 40.985 vs INNV: 17.64

InnovAge Holding had a gross margin of 16.84% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for InnovAge Holding was -9.50% per year.


InnovAge Holding Gross Margin % Historical Data

The historical data trend for InnovAge Holding's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnovAge Holding Gross Margin % Chart

InnovAge Holding Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Gross Margin %
Get a 7-Day Free Trial 24.91 27.29 19.38 14.72 17.29

InnovAge Holding Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.28 17.79 17.61 18.34 16.84

Competitive Comparison of InnovAge Holding's Gross Margin %

For the Medical Care Facilities subindustry, InnovAge Holding's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InnovAge Holding's Gross Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, InnovAge Holding's Gross Margin % distribution charts can be found below:

* The bar in red indicates where InnovAge Holding's Gross Margin % falls into.



InnovAge Holding Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

InnovAge Holding's Gross Margin for the fiscal year that ended in Jun. 2024 is calculated as

Gross Margin % (A: Jun. 2024 )=Gross Profit (A: Jun. 2024 ) / Revenue (A: Jun. 2024 )
=132.1 / 763.855
=(Revenue - Cost of Goods Sold) / Revenue
=(763.855 - 631.791) / 763.855
=17.29 %

InnovAge Holding's Gross Margin for the quarter that ended in Sep. 2024 is calculated as


Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=34.5 / 205.142
=(Revenue - Cost of Goods Sold) / Revenue
=(205.142 - 170.601) / 205.142
=16.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


InnovAge Holding  (NAS:INNV) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

InnovAge Holding had a gross margin of 16.84% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


InnovAge Holding Gross Margin % Related Terms

Thank you for viewing the detailed overview of InnovAge Holding's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


InnovAge Holding Business Description

Traded in Other Exchanges
N/A
Address
8950 East Lowry Boulevard, Denver, CO, USA, 80230
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.
Executives
Nicole Damato officer: CHIEF LEGAL OFFICER 8950 E. LOWRY BOULEVARD, DENVER CO 80230
Teresa Sparks director 40 BURTON HILLS BOULEVARD SUITE 500, NASHVILLE TN 37215
Benjamin C Adams officer: CHIEF FINANCIAL OFFICER 8950 E. LOWRY BOULEVARD, DENVER CO 80230
Patricia Fontneau director 8950 E. LOWRY BOULEVARD, DENVER CO 80230
Christine Bent officer: CHIEF OPERATIONS OFFICER 8950 E. LOWRY BOULEVARD, DENVER CO 80230
Thomas Scully director 320 PARK AVENUE, SUITE # 2500, NEW YORK NM 10022
Richard Feifer officer: CHIEF MEDICAL OFFICER C/O GENESIS HEALTHCARE, INC., 101 EAST STATE STREET, KENNETT SQUARE PA 19348
James G Carlson director 8950 E. LOWRY BOULEVARD, DENVER CO 80230
Patrick T Blair officer: PRESIDENT 8950 E. LOWRY BOULEVARD, DENVER CO 80230
Caroline Dechert director 580 CALIFORNIA ST., SUITE 1700, SAN FRANCISCO CA 94104
Pavithra Mahesh director 601 LEXINGTON AVE., 53RD FLOOR, NEW YORK NY 10022
Maureen Hewitt director, officer: CEO, President and Director 8950 E. LOWRY BLVD., DENVER CO 80230
Maria Lozzano officer: CORPORATE COO 8950 E. LOWRY BLVD., DENVER CO 80230
Robin Doerr officer: CHIEF SALES AND MKTG. OFFICER 8950 E. LOWRY BLVD., DENVER CO 80230
Melissa Welch officer: CHIEF MEDICAL OFFICER 8950 E. LOWRY BLVD., DENVER CO 80230